Literature DB >> 2426355

Monoclonal anti-Fc epsilon receptor antibodies with different specificities and studies on the expression of Fc epsilon receptors on human B and T cells.

M Suemura, H Kikutani, E L Barsumian, Y Hattori, S Kishimoto, R Sato, A Maeda, H Nakamura, H Owaki, R R Hardy.   

Abstract

Three monoclonal antibodies, 1-7 (gamma 2b), 3-5 (gamma 1), and 8-30 (mu), specific to Fc epsilon receptors (Fc epsilon R) on human B cells were established. The two monoclonals (1-7 and 8-30) could inhibit the binding of IgE to Fc epsilon R in rosette formation assays, as well as FACS analysis, and were shown to recognize the same epitope of Fc epsilon R. The other monoclonal antibody (3-5) recognized the same molecule but a different epitope, and marginally inhibited the IgE binding. The molecules on RPMI 8866 cells recognized by these monoclonal antibodies had Mr of 46,000 and 25,000 to 30,000 daltons as determined by immunoprecipitation and SDS-PAGE analysis. By employing these monoclonal antibodies, the expression of Fc epsilon R on circulating lymphocytes was studied. Approximately 50% of B cells from normal, nonatopic individuals were found to express Fc epsilon R, and a remarkable increase in the expression of Fc epsilon R was observed in B cells of atopic patients. The expression of Fc epsilon R was not detected in T cells from atopic patients (including hyper IgE syndrome) as well as normal individuals. Incubation of B cells with PHA-conditioned medium plus IgE augmented the expression of Fc epsilon R in the Fc epsilon R+ B cell population but not in Fc epsilon R- population. PHA-conditioned medium plus IgE did not induce Fc epsilon R expression on T cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2426355

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  Two forms of the low-affinity Fc receptor for IgE differentially mediate endocytosis and phagocytosis: identification of the critical cytoplasmic domains.

Authors:  A Yokota; K Yukawa; A Yamamoto; K Sugiyama; M Suemura; Y Tashiro; T Kishimoto; H Kikutani
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

2.  Sequence of the Lyb-2 B-cell differentiation antigen defines a gene superfamily of receptors with inverted membrane orientation.

Authors:  E Nakayama; I von Hoegen; J R Parnes
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

Review 3.  Regulation of IgE synthesis. Lymphocyte Fc epsilon receptor, IgE binding factor(s), and glycosylation-modulating factors.

Authors:  J Yodoi; T Kawabe; M Takami
Journal:  Clin Rev Allergy       Date:  1989

Review 4.  Low affinity IgE receptors (Fc epsilon RII).

Authors:  D H Conrad
Journal:  Clin Rev Allergy       Date:  1989

Review 5.  The receptor for the Fc region of IgE.

Authors:  A D Keegan; D H Conrad
Journal:  Springer Semin Immunopathol       Date:  1990

6.  Subset of natural killer cells is induced by immune complexes to display Fc receptors for IgE and IgA and demonstrates isotype regulatory function.

Authors:  H Kimata; A Saxon
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

7.  Regulation of Fc epsilon receptor expression on a human monoblast cell line U937.

Authors:  M Mayumi; T Kawabe; K M Kim; T Heike; K Katamura; J Yodoi; H Mikawa
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

8.  Regulation of IgE receptor expression on human peripheral blood lymphocytes by lymphocytosis promoting factor (LPF), lectins and dexamethasone.

Authors:  K M Kim; M Tanaka; T Yoshimura; K Katamura; M Mayumi; H Mikawa
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

Review 9.  B-cell stimulatory factors (BSFs): molecular structure, biological function, and regulation of expression.

Authors:  T Kishimoto
Journal:  J Clin Immunol       Date:  1987-09       Impact factor: 8.317

Review 10.  Eosinophil IgE receptor and CD23.

Authors:  M Capron; M J Truong; D Aldebert; V Gruart; M Suemura; G Delespesse; B Tourvieille; A Capron
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.